Owens & Minor, Inc.
Owens & Minor, Inc. (OMI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
omi · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Owens & Minor, Inc. (OMI) measures how much investors pay for each dollar of the company's trailing earnings. OMI's current PE ratio of N/A is calculated by dividing its stock price of $2.68 by its TTM earnings per share of -$14.11.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 15 fiscal years · Front-end computedMinQ1 · 25%19.8x
MedianQ3 · 75%65.0x
Max
At N/A, OMI's current P/E is lower than in 0% of its annual fiscal year readings over the past 15 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Distribution · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Owens & Minor, Inc.You OMI | $207M | N/A | — | -$14.11 |
 Aclaris Therapeutics, Inc. ACRS | $526M | N/A | — | -$0.53 |
 Allogene Therapeutics, Inc. ALLO | $451M | N/A | — | -$0.87 |
 BioAge Labs, Inc. BIOA | $584M | N/A | — | -$2.24 |
 Cabaletta Bio, Inc. CABA | $522M | N/A | — | -$1.64 |
 Canopy Growth Corporation CGC | $434M | N/A | — | -$5.56 |
 CVRx, Inc. CVRX | $143M | N/A | — | -$2.04 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-14.24 | — | |
2024-12-31 FY2024 | — | $-4.73 | — | |
2023-12-31 FY2023 | — | $-0.54 | — | |
2022-12-31 FY2022 | 64.98x | $0.30 | +355.1% | |
2021-12-31 FY2021 | 14.28x | $3.05 | -75.1% | |
2020-12-31 FY2020 | 57.38x | $0.47 | — | |
2019-12-31 FY2019 | — | $-1.03 | — | |
2018-12-31 FY2018 | — | $-7.28 | — | |
2017-12-31 FY2017 | 15.56x | $1.21 | -21.5% | |
2016-12-31 FY2016 | 19.82x | $1.78 | -8.3% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Owens & Minor, Inc. (OMI) measures how much investors pay for each dollar of the company's trailing earnings. OMI's current PE ratio of N/A is calculated by dividing its stock price of $2.68 by its TTM earnings per share of -$14.11.
Frequently asked questions
OMI pe ratio · 6 questionsOMI's current PE ratio is N/A as of 2026-06-08, based on a stock price of $2.68 and TTM EPS of -$14.11. Data sourced from Financial Modeling Prep via OMI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Owens & Minor, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08